About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Validation of New Therapeutic Regimens for Cryptococcal Meningitis

by Anjali Aryamvally on March 17, 2018 at 1:35 PM
Font : A-A+

Validation of New Therapeutic Regimens for Cryptococcal Meningitis

The results of the ACTA trial show that new therapeutic regimens are of benefit in HIV-infected patients with cryptococcal meningitis. The findings were presented at the 9th IAS Conference on HIV Science held in Paris from 23 to 26 July 2017.

The study was conducted by Professor Thomas Harrison and his colleagues at St George's University of London, the Institut Pasteur in Paris, Paris Descartes University (Hôpital Necker-Enfants Malades), the ANRS site in Cameroon, and the MRC sites in Malawi, Tanzania, and Zambia.

Advertisement


Cryptococcal meningitis is a serious fungal infection frequent in immunosuppressed people, in particular AIDS patients. Despite increased use globally of antiretroviral treatment of people living with HIV, cryptococcal disease has not declined in incidence and accounts for over 180 000 deaths worldwide every year.

The ACTA trial in 721 HIV-infected patients with cryptococcal meningitis compared three 1- or 2-week induction treatments of this fungal infection, followed by 8- to 9-week consolidation therapy. The most effective was 1-week induction treatment comprising daily infusion of amphotericin B and oral flucytosine followed by two weeks of fluconazole and flucytosine. Ten weeks after treatment initiation, mortality had dropped significantly compared with the therapeutic regimen recommended hitherto in several countries. These results are reported in the New England Journal of Medicine.
Advertisement

The new therapeutic regimens highlighted by the ACTA trial could potentially save over 80 000 lives a year. In the light of these findings, the WHO has just changed its guidelines for the management of cryptococcal disease and recommends 1-week induction treatment based on amphotericin B and flucytosine. If amphotericin is unavailable, high-dose fluconazole combined with oral flucytosine should be proposed. Olivier Lortholary and Charles Kouanfack, the investigators for the ANRS Cameroon site concluded that "These results will have a major impact on AIDS-related mortality in Africa. They show that flucytosine should rapidly be made available in resource-limited countries."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hib Vaccine Meningitis Cryptococcal Meningitis 

Recommended Reading
Study: Change in Treatment Regime for Cryptococcal Meningitis may be Needed
According to the findings of a study, the most cost-effective treatment for cryptococcal meningitis ...
Vaccines For Pneumonia, Meningitis Reduce Healthcare Cost Burden
The economic impact of Gavi, the global vaccine alliance is estimated to prevent 20 million deaths ....
Spinal Meningitis Threatens Lives of 450 Million Africans
Meningococcal meningitis is a global burden that affects 1.2 million people every year and causes .....
World Health Organization Urges Routine Meningitis Vaccine To Avoid Resurgence
Mass vaccination campaigns of meningitis A vaccine have led to the control and near elimination of ....
Cryptococcal Meningitis
Cryptococcal meningitis is a fungal infection affecting the coverings of the brain (meninges). It is...
Hib Vaccine
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused b...
Meningitis
Meninges are the three layers of membrane that cover the brain and infection of the cerebrospinal fl...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use